PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells

PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells

This study aims to design a pH-responsive dual-loaded nanosystem based on PEGylated chitosan nanoparticles loaded with ascorbic acid (AA) and oxaliplatin (OX) for the effective treatment of breast cancer. In this regard, non-PEGylated and PEGylated chitosan nanoparticles (CS NPs) loaded with either...

Full description

Bibliographic Details
Main Authors:	Sherif Ashraf Fahmy, Asmaa Ramzy, Asmaa A. Mandour, Soad Nasr, Anwar Abdelnaser, Udo Bakowsky, Hassan Mohamed El-Said Azzazy
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Pharmaceutics
Subjects:	chitosan nanoparticles PEG oxaliplatin ascorbic acid (vitamin C) ionic gelation method breast cancer
Online Access:	https://www.mdpi.com/1999-4923/14/2/407

Similar Items

Host-Guest Complexation of Oxaliplatin and <i>Para-</i>Sulfonatocalix[n]Arenes for Potential Use in Cancer Therapy
by: Sherif Ashraf Fahmy, et al.
Published: (2020-12-01)

Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin
by: Emiliane Daher Pereira, et al.

Oxaliplatin-Associated Amaurosis Fugax
by: Kimitoshi Kubo, et al.
Published: (2021-06-01)

Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth
by: Ana S. Pires, et al.
Published: (2018-07-01)

PEG Gels Significantly Improve the Storage Stability of Nucleic Acid Preparations
by: Pengfei Cui, et al.
Published: (2022-12-01)

Establishment of the menthol test as a clinical evaluation method for oxaliplatin-induced neuropathy
by: Yeongcheol Cheong, et al.
Published: (2022-08-01)

Co-Delivery of Ylang Ylang Oil of <i>Cananga odorata</i> and Oxaliplatin Using Intelligent pH-Sensitive Lipid-Based Nanovesicles for the Effective Treatment of Triple-Negative Breast Cancer
by: Nada K. Sedky, et al.
Published: (2023-05-01)

Adsorption of Oxaliplatin by Hydroxyapatite
by: Papageorgiou A., et al.
Published: (2007-12-01)

Increase in spleen volume as a predictor of oxaliplatin toxicity
by: El Chediak A, et al.
Published: (2018-04-01)

A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
by: Ezanno Anne-Cecile, et al.
Published: (2022-01-01)

Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
by: Nobuaki Egashira, et al.
Published: (2021-09-01)

Preparations for colon capsule endoscopy: prospective and randomized comparative study between two preparations for colon capsule endoscopy: PEG 2 liters + ascorbic acid versus PEG 4 liters
by: Federico Argüelles-Arias, et al.
Published: (2014-05-01)

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
by: Masanobu Tsubaki, et al.
Published: (2023-04-01)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
by: Guido Cavaletti, et al.
Published: (2020-05-01)

Different Apoptotic Pathways Activated by Oxaliplatin in Primary Astrocytes vs. Colo-Rectal Cancer Cells
by: Matteo Zanardelli, et al.
Published: (2015-03-01)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
by: Yuanyuan Yu, et al.
Published: (2021-05-01)

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
by: A.F. Pereira, et al.
Published: (2020-09-01)

Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer
by: Sung Bum Kim, et al.
Published: (2020-11-01)

Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
by: Renata Ferrarotto, et al.
Published: (2013-09-01)

First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
by: Bengang Huo, et al.
Published: (2023-12-01)

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review
by: Francesca Barbin, et al.
Published: (2022-12-01)

Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats
by: Rong Ding, et al.
Published: (2020-12-01)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
by: Andreas A. Argyriou
Published: (2015-05-01)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
by: Qing-nan Zhou, et al.
Published: (2023-05-01)

PEGylated Chitosan Nanoparticles Loaded with Betaine and Nedaplatin Hamper Breast Cancer: In Vitro and In Vivo Studies
by: Sherif Ashraf Fahmy, et al.
Published: (2023-10-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report
by: İsmail Beypinar, et al.
Published: (2017-04-01)

Oxaliplatin-Associated Takotsubo Cardiomyopathy in a Patient with Metastatic Gastric Cancer: A Case Report
by: Luis Miguel Osorio-Toro, et al.
Published: (2023-08-01)

Amaurosis Fugax: A Rare Oxaliplatin-Induced Ocular Toxicity – A Report of Three Cases
by: Mutahar Ali Tunio, et al.
Published: (2022-02-01)

Oxaliplatin-resistant colorectal cancer models for nanoparticle hyperthermia
by: Bryce McCarthy, et al.
Published: (2021-01-01)

Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial
by: Yanfei Liu, et al.
Published: (2024-03-01)

Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
by: Alessio Amatu, et al.
Published: (2022-02-01)

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
by: Mohammad Ali Mashhadi, et al.
Published: (2016-10-01)

Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer
by: Zhi-Qiang Wang, et al.
Published: (2016-01-01)

EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells
by: Fen Hu, et al.
Published: (2015-05-01)

Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer
by: Beatriz Garcia-Pinel, et al.
Published: (2020-06-01)

Expression of ENO3 and Its Effect on Sensitivity of Hepatocellular Carcinoma Cells to Oxaliplatin
by: CUI Honglei, et al.
Published: (2022-05-01)

Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer
by: I. Grivicich, et al.
Published: (2001-09-01)

Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
by: Li Y, et al.
Published: (2020-09-01)

Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: A retrospective analysis from a medical center
by: Yung-Chia Kuo, et al.
Published: (2014-06-01)